Court To Evaluate Expert Testimony Linking Side Effects Zantac and Cancer Next Week
Daubert hearings for expert witnesses slated for Zantac cancer trials will begin on September 21.
Tag Archives: NDMA
-
-
Zantac Settlement Reached By Certain Generic Drug Makers Before Trial Against GSK Dropped: Report
A Zantac lawsuit was settled by generic drug makers, and dropped against GSK just days before trial was set to begin in an Illinois state court.
-
Zantac Lawsuit Payouts and Settlement Costs Cause Concerns Among Drug Company Investors
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
-
Series of Four Zantac Lawsuits Set For Trial Next Year in California State Court
The first California Zantac bellwether trials have been pushed back to February 2023.
-
Drug Makers Challenge Expert Testimony Linking Zantac to Cancer Risk
Makers of brand-name drugs want a federal judge to exclude expert witnesses for plaintiffs, seeking a summary judgment to have Zantac cancer risk lawsuits dismissed before they can make it…
-
Daubert Hearings for Zantac Cancer Lawsuits To Be Held in September 2022
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
-
Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
-
Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
-
Zantac MDL Judge Indicates “Time Has Come” To Finalize Registry Data for Pending Claims
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
-
Zantac MDL Moving Forward With Expert Support For Causing Bladder, Esophageal, Gastric, Liver and Pancreatic Cancers
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.